The goal of the Oncolytic Virus Fund is to collect money for research on cancer-destroying (oncolytic) viruses and cancer therapeutics for neuroendocrine tumours. With sufficient funds, we will be able to launch the world's first human trial of an engineered virus that targets neuroendocrine cancer. For an interesting read -- see The Telegraph's article about Magnus Essand's research http://www.telegraph.co.uk/science/9508895/A-virus-that-kills-cancer-the... More information about the research is available at the website of the Department of Immunology, Genetics and Pathology - http://www.igp.uu.se/Research and at the Uppsala University Hospitals Center of Excellence for Endocrine Tumors http://www.akademiska.se/endocrinetumors/ /clinical_immunology/magnus_essand/more/?languageId=1 Magnus Essand, professor at Department of Immunology, Genetics and Pathology, Clinical Immunology, Uppsala University, Sweden How to donate: The Oncolytic Virus Fund http://bit.ly/RAGqqv